glp-1 use GLP-1s GLP-1 Antagonists Increase Plan Drug

McKillop, D

[DOI] [PMC free article] [PubMed] [Google Scholar] 86.Koeth R.A., Wang Z., Levison B.S., Buffa J.A., Org E., Sheehy B.T., Britt E.B., Fu X., Wu Y., Li L., et al

Ethics declarations Authors relationships and activities TV has served on scientific advisory panels, been part of speaker bureaus, and served as a consultant to and/or received research support from Amgen, AstraZeneca, Boehringer Ingelheim, Eli Lilly, Gilead, GSK, Mundipharma, Novo Nordisk, Sanofi and Sun Pharmaceuticals

In nutritional excess and obesity states, BCAA circulating levels are typically already elevated, reflecting BCAA metabolic dysfunction rather than insufficient intake (72)

Adjust injection timing (if needed): Some patients find the timing of their GLP-1 dose can influence side effects